PT Medikaloka Hermina Tbk · IDX:HEAL
PT Medikaloka Hermina Tbk — Investor Presentation (July 2018)
17 slides from PT Medikaloka Hermina Tbk's investor presentation, July 2018
Slide 1: PT Medikaloka Hermina Tbk 1H 2018 Presentation
PT Medikaloka Hermina Tbk 1H 2018 Presentation July 2018
Slide 2: Hermina – Our Team
Hermina – Our Team #1 Indonesia Original Brand in Maternity Hospital (2016) - SWA President 34 dr. Hasmoro Director & CEO Years of Experience Co-Founder and MD, 34 Yulisar Khiat Operational and Years of Experience General Affairs Co-Founder and MD, dr. Binsar Parasian 32 Medical and Simorangkir Year
Slide 3: 1. Company Overview
pH s AN 4 2 i a “ ra 1. Company Overview HERMINA
Slide 4: Leading National Hospital Chain, with Robust Growth Trajectory
Leading National Hospital Chain, with Robust Growth Trajectory One of the Largest Groups in a Highly Fragmented Indonesian Hospital Market1 Top 5 Private Operators by Number of Hospitals # of Hospitals Other Selected Top Players, Beyond the Top 5 # of Operational Beds Type of Name No. of Hospitals N
Slide 5: Service Offering Overview
Service Offering Overview Hermina hospitals are a network of general hospitals with a significant strength and wide offering in women and children care Hermina Hospital Facility Type B • 6 Type B general hospitals with fully 6 hospitals advanced center of excellence & sub- specialist care Pharmacy R
Slide 6: Corporate History
Corporate History Company Milestones ◼ Established 3 new hospitals and ◼ Changed the non-profit ◼ Established the first ◼ Made the first acquired 2 hospitals ◼ 2017: Established 4 new hospitals organization status into a maternity hospital in acquisition of a ◼ 2005: Pandanaran became the ◼ Company
Slide 7: Our Nationwide Hospital Network
Our Nationwide Hospital Network Our Nationwide Hospital Network Type B Hospitals Type C Hospitals • Pasteur • Palembang • Yogya • Pandanaran • Ciputat • Bitung • Malang • Cileungsi • Makassar Jatinegara Kemayoran Bekasi • Sukabumi • Serpong • Balikpapan • Tangerang • Banyumanik • Medan • Grand Wisat
Slide 8: 2. Financial Update
pH s AN 4 2 i a 7 ra 2. Financial Update HERMINA
Slide 9: Robust Growth in Revenue and Stable Margin Profile
Robust Growth in Revenue and Stable Margin Profile Total Revenue Gross Profit & Gross Margin (IDR billions) (IDR billions, %) Growth: 18.2% 44.5% 43.8% 50.0% 1,515.4 1,200.0 40.0% 1,281.8 30.0% 664.2 700.0 569.9 20.0% 10.0% 200.0 0.0% 1H17 1H18 1H17 1H18 Gross Profit Gross Margin EBITDA & EBITDA Mar
Slide 10: Key Balance Sheet Items – Working Capital Turnover Days
Key Balance Sheet Items – Working Capital Turnover Days Trade Receivable Days1 Net Working Capital (Days) (IDR billions) 63.1 53.6 361.4 355.0 33.7 36.8 205.4 2015 2016 2017 1H18 76.6 Inventory Days (Days) 2015 2016 2017 1H18 11.8 13.0 11.0 9.7 Cash Conversion Cycle Days (Days) 2015 2016 2017 1H18 T
Slide 11: Strong Growth in Patient Visits
Strong Growth in Patient Visits Inpatient Days Inpatient Admissions by Payor Type Growth: 29.0% Non- Non- JKN, 363K JKN, JKN, 33% 281K 53% JKN, 47% 67% 1H17 1H18 1H17 1H18 Outpatient Visit Outpatient Visits by Payor Type Growth: 24.4% 2.6M 2.1M JKN, Non- Non- 41% JKN, JKN, 49% JKN, 51% 59% 1H17 1H18
Slide 12: EBITDA Calculation Methodology
EBITDA Calculation Methodology (IDR billions) 1H17 1H18 YoY Growth Revenue 1,281.8 1,515.4 18.2% EBIT 196.6 210.3 7.0% % Margin 15.3% 13.9% Depreciation and Amortization (D&A) 64.4 93.0 Adjustment for back non-cash items1 13.0 13.2 Post-employment benefits 11.4 12.2 Allowance for impairment losses 1
Slide 13: Debt and Leverage Ratio
Debt and Leverage Ratio Total Debt / Net Debt / Leverage Ratio Maturity Profile (June 2018) (IDR billions, x) 1.9 2 2500 <1 yr 1.5 maturity 15% 2000 1 0.8 0.7 1500 1,422.0 0.5 IDR 0.5 865.2 bn 1,099.6 1000 865.2 0 607.7 1-5 yr 500 404.5 maturity 354.1 343.3 -0.5 85% 235.3 0 -1 2015 2016 2017 1H18 To
Slide 14: Cash Flow and Capital Expenditure
Cash Flow and Capital Expenditure Cash Flow Cash and Cash Equivalents (IDR billions) (IDR billions) 521.9 322.4 1,142.4 203.2 170.2 118.8 176.5 446.3 331.4 393.6 439.7 207.7 2015 2016 2017 1H18 (526.7) (485.7) (454.5) (1,462.8) Capital Expenditure1 (IDR billions, %) 40.0% 1350 30.9% 29.7% 35.0% 1150
Slide 15: 3. Hospital Development
pH s AN 4 2 i a 7 ra 3. Hospital Development HERMINA
Slide 16: Hospitals Under Development
Hospitals Under Development Hermina Jakabaring Ground Piled & Finishing Opening Breaking Structure Architecture PLAN Aug Sep-Dec 2017 Jan-Jul 2018 3Q18 2017 PROGRESS 100% 100% 97% Hermina Padang Ground Piled & Finishing Breaking Structure Architecture Opening PLAN Oct Nov 2017 - Jul 2018 Jul-Oct 201
Slide 17: PT Medikaloka Hermina Tbk www.herminahospitals.com
PT Medikaloka Hermina Tbk www.herminahospitals.com
PT Medikaloka Hermina — Investor Presentation (July 2018) on 6ix